These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18665430)

  • 1. Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer.
    Kaushal S; McElroy MK; Luiken GA; Talamini MA; Moossa AR; Hoffman RM; Bouvet M
    J Gastrointest Surg; 2008 Nov; 12(11):1938-50. PubMed ID: 18665430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Curative Fluorescence-Guided Surgery of Pancreatic Cancer.
    Bouvet M; Hoffman RM
    Hepatogastroenterology; 2015 May; 62(139):715-22. PubMed ID: 26897960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
    Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
    Metildi CA; Kaushal S; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
    J Surg Oncol; 2014 Apr; 109(5):451-8. PubMed ID: 24249594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice.
    Hiroshima Y; Maawy A; Sato S; Murakami T; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Surg Res; 2014 Apr; 187(2):510-7. PubMed ID: 24373959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system.
    Hiroshima Y; Maawy A; Metildi CA; Zhang Y; Uehara F; Miwa S; Yano S; Sato S; Murakami T; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Laparoendosc Adv Surg Tech A; 2014 Apr; 24(4):241-7. PubMed ID: 24494971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
    Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation.
    McElroy M; Kaushal S; Luiken GA; Talamini MA; Moossa AR; Hoffman RM; Bouvet M
    World J Surg; 2008 Jun; 32(6):1057-66. PubMed ID: 18264829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.
    Gutowski M; Framery B; Boonstra MC; Garambois V; Quenet F; Dumas K; Scherninski F; Cailler F; Vahrmeijer AL; Pèlegrin A
    Surg Oncol; 2017 Jun; 26(2):153-162. PubMed ID: 28577721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative detection of colorectal and pancreatic liver metastases using SGM-101, a fluorescent antibody targeting CEA.
    Meijer RPJ; de Valk KS; Deken MM; Boogerd LSF; Hoogstins CES; Bhairosingh SS; Swijnenburg RJ; Bonsing BA; Framery B; Fariña Sarasqueta A; Putter H; Hilling DE; Burggraaf J; Cailler F; Mieog JSD; Vahrmeijer AL
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):667-673. PubMed ID: 33158638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.
    Hiroshima Y; Lwin TM; Murakami T; Mawy AA; Kuniya T; Chishima T; Endo I; Clary BM; Hoffman RM; Bouvet M
    J Surg Oncol; 2016 Dec; 114(8):951-958. PubMed ID: 27696448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer.
    Lwin TM; Hernot S; Hollandsworth H; Amirfakhri S; Filemoni F; Debie P; Hoffman RM; Bouvet M
    Surgery; 2020 Jul; 168(1):85-91. PubMed ID: 32370916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.
    Boogerd LSF; Hoogstins CES; Schaap DP; Kusters M; Handgraaf HJM; van der Valk MJM; Hilling DE; Holman FA; Peeters KCMJ; Mieog JSD; van de Velde CJH; Farina-Sarasqueta A; van Lijnschoten I; Framery B; Pèlegrin A; Gutowski M; Nienhuijs SW; de Hingh IHJT; Nieuwenhuijzen GAP; Rutten HJT; Cailler F; Burggraaf J; Vahrmeijer AL
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):181-191. PubMed ID: 29361435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
    Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantages of fluorescence-guided laparoscopic surgery of pancreatic cancer labeled with fluorescent anti-carcinoembryonic antigen antibodies in an orthotopic mouse model.
    Metildi CA; Kaushal S; Luiken GA; Hoffman RM; Bouvet M
    J Am Coll Surg; 2014 Jul; 219(1):132-41. PubMed ID: 24768506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved antibody-guided surgery with a near-infrared dye on a pegylated linker for CEA-positive tumors.
    Yazaki P; Lwin T; Minnix M; Li L; Sherman A; Molnar J; Miller A; Frankel P; Chea J; Poku E; Bowles N; Hoffman R; Shively J; Bouvet M
    J Biomed Opt; 2019 Jun; 24(6):1-9. PubMed ID: 31254333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model.
    DeLong JC; Murakami T; Yazaki PJ; Hoffman RM; Bouvet M
    J Surg Res; 2017 Oct; 218():139-143. PubMed ID: 28985840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPECT- and fluorescence image-guided surgery using a dual-labeled carcinoembryonic antigen-targeting antibody.
    Rijpkema M; Oyen WJ; Bos D; Franssen GM; Goldenberg DM; Boerman OC
    J Nucl Med; 2014 Sep; 55(9):1519-24. PubMed ID: 24982436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An LED light source and novel fluorophore combinations improve fluorescence laparoscopic detection of metastatic pancreatic cancer in orthotopic mouse models.
    Metildi CA; Kaushal S; Lee C; Hardamon CR; Snyder CS; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
    J Am Coll Surg; 2012 Jun; 214(6):997-1007.e2. PubMed ID: 22542065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.
    Boonstra MC; Tolner B; Schaafsma BE; Boogerd LS; Prevoo HA; Bhavsar G; Kuppen PJ; Sier CF; Bonsing BA; Frangioni JV; van de Velde CJ; Chester KA; Vahrmeijer AL
    Int J Cancer; 2015 Oct; 137(8):1910-20. PubMed ID: 25895046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.